A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
Abstract Enterovirus 71 (EV71) is an aetiological agent responsible for seasonal epidemics of hand-foot-and-mouth disease, which causes considerable mortality among young children. Mucosal vaccines can efficiently induce secretory IgA at mucosal surfaces and thereby prevent or limit infection at the...
Guardado en:
Autores principales: | Yu-Li Lin, Yen-Hung Chow, Li-Min Huang, Szu-Min Hsieh, Pei-Yun Cheng, Kai-Chieh Hu, Bor-Luen Chiang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/69cf232c02d7459f8003b94ae0bbb033 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Flt3 ligand treatment reduces enterovirus A71 lethality in mice with enhanced B cell responses
por: Yu-Wen Lin, et al.
Publicado: (2018) -
Low biological fluctuation of mitochondrial CpG and non-CpG methylation at the single-molecule level
por: Chloe Goldsmith, et al.
Publicado: (2021) -
The interplays between autophagy and apoptosis induced by enterovirus 71.
por: Xueyan Xi, et al.
Publicado: (2013) -
Inactivated enterovirus A71 vaccines and moving forward
por: Hiroyuki Shimizu
Publicado: (2021) -
CpG-Based Nanovaccines for Cancer Immunotherapy
por: Chen W, et al.
Publicado: (2021)